Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,101–1,125 of 27,380 studies, newest first · page 45 of 1096.

June 2026 25

  1. 2026-06-09

    Predicting Mild Cognitive Impairment to Alzheimer's Disease Progression by Explainable Multi‐Modal Framework Using Deep and Machine Learning Hybrid Model

    ✓ Peer-reviewed Mild cognitive impairment International Journal of Imaging Systems and Technology

    Key finding: Accurate prediction of the progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is essential for early intervention and effective disease management.

  2. 2026-06-09

    Optimizing Plasma p-tau217 Thresholds for Detection of Preclinical Alzheimer’s Disease Across Different Racial and Ethnic Backgrounds (P10-13.011)

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: To evaluate plasma p-tau217 ability to detect pre-symptomatic Alzheimer disease (AD) in ethnoracially diverse cognitively normal individuals.

  3. 2026-06-09

    β-amyloid PET Signal Reduction in Regions with ARIA-E Following Anti-amyloid Therapy for Alzheimer Disease (P1-12.010)

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: To determine the relationship between regional brain edema caused by anti-amyloid monoclonal antibody therapy (ARIA-E) and the degree of regional β-amyloid (Aβ) positron emission tomography (PET) signal reduction.

  4. 2026-06-09

    Estimating the Effect of Hospital Admission on Health Care Outcomes and Spending Among Persons With Dementia : A Quasi-experimental Study

    ✓ Peer-reviewed Costs and economics Annals of internal medicine

    Key finding: Among Medicare beneficiaries with dementia who visited an ED, there was no evidence that hospital admission was associated with mortality rates. +4 more findings

  5. 2026-06-08

    Connecting the Dots in Parkinson’s care: A Rapid Review and Qualitative Synthesis of Multidisciplinary Patient Passports for Parkinson’s disease

    ⚠ Preprint — not yet peer-reviewed End-of-life care Research Square

    Key finding: Forty‑two studies published between 1997 and 2025 were included.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  6. 2026-06-08

    Epigenetic Age and Resilience in the Framingham Heart Study

    ✓ Peer-reviewed Tau biomarkers Neurology open access

    Key finding: Independent of t-tau and TCBV, epigenetic age measures were associated with time to MCI, AD, and all-cause dementia and baseline cognition, but not with cognitive trajectories. +4 more findings

  7. 2026-06-08

    Bias from small-count suppression in county-level cancer disparity estimates: a calibrated simulation study

    ✓ Peer-reviewed Risk factors Not indexed

    Key finding: The suppressed fraction rose with rarity: 7.4% of counties for breast, 61.3% for stomach, and 75.7% for cervix incidence. +1 more finding

  8. 2026-06-08
  9. 2026-06-08

    Early recognition of delirium in hospitalized patients: an underutilized clinical priority

    ✓ Peer-reviewed Clinical safety Annals of Medicine and Surgery

    Key finding: Importantly, delirium is not merely a transient cognitive fluctuation; it is independently associated with increased short- and long-term mortality, longer hospital stays, higher healthcare costs, and persistent cognitive impairment comparable to mild dementia[4,5]. +4 more findings

  10. 2026-06-08

    Characterization of the Anti-Alzheimer Drug Lecanemab by Mass Spectrometry

    ✓ Peer-reviewed Treatments ACS Omega

    Key finding: These results provide data as resource for the identification of critical quality attributes of lecanemab in studying its therapeutic effectiveness, side effects, and possible batch-to-batch qualities.

  11. 2026-06-08

    Socioeconomic disparities and nutritional aging: how food insecurity and financial hardship accelerate health decline in older adults

    ✓ Peer-reviewed Risk factors Frontiers in Nutrition

    Key finding: Food insecurity and financial hardship are consistently associated with poorer diet quality, including lower Healthy Eating Index scores (e.g., ~51 vs. >57 in food-secure peers), and increased risk of adverse outcomes such as sarcopenia, frailty, and cognitive decline.

  12. 2026-06-06

    Dementia and Frailty Impact Postoperative Care Trajectories and Burden among Older Adults Undergoing Radical Cystectomy for Bladder Cancer

    ⚠ Preprint — not yet peer-reviewed Costs and economics medRxiv

    Key finding: Patients with dementia were more likely to be frail, comorbid, and not receive standard-of-care neoadjuvant chemotherapy. +2 more findings

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  13. 2026-06-06

    Revisão sistemática: Biomarcadores séricos no diagnóstico precoce da doença de Alzheimer

    ✓ Peer-reviewed Tau biomarkers Research Society and Development

    Key finding: Foi realizada uma busca sistemática nas bases de dados PubMed, Scopus e Web of Science, utilizando descritores relacionados à doença de Alzheimer, biomarcadores séricos e diagnóstico precoce. +4 more findings

  14. 2026-06-05

    TDP-43 oxidation and PP1 crosstalk at RNA granule-mitochondria contact sites

    ✓ Peer-reviewed Brain tissue and pathology Nature Communications

    Key finding: This dynamic crosstalk between TDP-43 oxidation and PP1 has significant consequences for TDP-43-associated diseases including Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

  15. 2026-06-05

    Blood-based biomarkers for early diagnosis of Alzheimer's disease: a current systematic review of diagnostic accuracy studies

    ✓ Peer-reviewed Tau biomarkers BMC neurology

    Key finding: Alzheimer disease (AD) is the most common cause of dementia in the world and its prevalence is increasing and it has important public health consequences. +3 more findings

  16. 2026-06-05
  17. 2026-06-04

    Assessment of potentially inappropriate medications using STOPPFrail V2 criteria and OncPal guideline in elderly cancer patients with end-stage disease: A cross-sectional study

    ⚠ Preprint — not yet peer-reviewed End-of-life care Research Square

    Key finding: Polypharmacy and PIMs are highly prevalent in end-of-life elderly cancer patients. +2 more findings

    Scored 39 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2026-06-04

    Reducing placebo response in clinical trials of agitation in Alzheimer’s disease

    ⚠ Preprint — not yet peer-reviewed Treatments medRxiv

    Key finding: Meta-regression identified several factors associated with increased placebo response, but most of these factors were non-specific such that they predicted improvements in drug response as well. +3 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  19. 2026-06-04

    The gut-brain axis in Alzheimer's disease: early detection, microbial metabolites, mechanisms, and therapeutic opportunities

    ✓ Peer-reviewed Disease mechanisms Frontiers in molecular biosciences

    Key finding: Emerging evidence indicates that microbial dysbiosis may influence key processes leading to AD, including neuroinflammation, amyloid and tau pathology, and cognitive decline. +2 more findings

  20. 2026-06-04

    Human microglial transitions at the Aβ-tau inflection point associate with divergent pathways to dementia and resilience

    ✓ Peer-reviewed Genetics Nature medicine

    Key finding: Together, these findings highlight divergent resilience-associated mechanisms in human aging and position microglial state transitions at the Aβ-tau interface as candidate points of resilience with potential therapeutic relevance.

  21. 2026-06-04

    Using the ascertain dementia eight-item questionnaire to identify at-risk older surgical patients

    ✓ Peer-reviewed Clinical safety Journal of Clinical Anesthesia

    Key finding: Of 689 participants, CI was associated with delirium (adjusted odds ratio [aOR]: 3.64, 95% CI: 1.31, 9.49, P-value = 0.009), 90-day complications (aOR: 2.26, 95% CI: 1.14, 4.28, P-value = 0.015), and 90-day composite adverse outcomes (aOR: 2.03, 95% CI: 1.03, 3.81, P-value = 0.033). +4 more findings

  22. 2026-06-04

    Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS study

    ✓ Peer-reviewed Risk factors Carolina Digital Repository (University of North Carolina at Chapel Hill)

    Key finding: Among 5757 participants (21.7% Black, 20.3% Latinx, 58.1% AORE), we found lower odds of amyloid positivity in Black (odds ratio [OR]: 0.72, 95% confidence interval [CI]: 0.62-0.83) and Latinx (OR: 0.78, 95% CI: 0.67-0.91) compared to AORE. +3 more findings

  23. 2026-06-04

    Chicago ZIP Code-Linked Area Deprivation Index as a Predictor of Dementia Diagnosis

    ✓ Peer-reviewed Risk factors University of Chicago

    Key finding: In this study, we examined whether a neighborhood-level, integrative measure of socioeconomic deprivation, the Area Deprivation Index (ADI), is associated with dementia diagnosis in the City of Chicago using archival data from neuropsychological evaluations from 2017-2025. +3 more findings

  24. 2026-06-04

    Chicago ZIP Code-Linked Area Deprivation Index as a Predictor of Dementia Diagnosis

    ✓ Peer-reviewed Risk factors Knowledge@UChicago (University of Chicago)

    Key finding: In this study, we examined whether a neighborhood-level, integrative measure of socioeconomic deprivation, the Area Deprivation Index (ADI), is associated with dementia diagnosis in the City of Chicago using archival data from neuropsychological evaluations from 2017-2025. +3 more findings

  25. 2026-06-04

    Consistency of a Dementia Diagnosis Between Systems for Patients Receiving Care Through the VA, Traditional Medicare, and Medicare Advantage

    ✓ Peer-reviewed Health systems and care delivery Medical Care

    Key finding: For VA and Medicare cohorts, dementia diagnosis was absent in 88.7% and 80.5%, respectively, of follow-up encounters in the other system. +4 more findings

Browse the library by subject, with the full score breakdown →